All Studies Meta Analysis Recent:

Synbiotic for Prevention of SARS-Cov2 Infection in High Risk Hospital Staffs: A Randomized Controlled Trial

Ahanchian et al., Open Journal of Nursing, doi:10.4236/ojn.2021.115025 , IRCT20101020004976N6

May 2021

Post
Facebook

Source PDF All Meta

Probiotics for COVID-19

17th treatment shown to reduce risk in March 2021

^*, now known with p = 0.0000013 from 26 studies.

Lower risk for mortality, hospitalization, progression, recovery, and cases.

No treatment is 100% effective. Protocols combine complementary and synergistic treatments. ^* >10% efficacy in meta analysis with ≥3 clinical studies.

4,000+ studies for 60+ treatments. c19early.org

Small RCT 60 healthcare workers in Iran, showing lower cases with treatment but without statistical significance. Once daily oral synbiotic capsule (Lactocare®) containing 1 billion CFU L. (Lactobacillus) casei, L. rhamnosus, Streptococcus thermophilus, Bifidobacterium breve, L. acidophilus, Bifidobacterium infantis, L. bulgaricus, and Fructooligosacharide.

The immune effects of probiotics are strain-specific.

Important missing comments or errors? Let us know.

respiratory symptoms, 73.3% lower, RR 0.27, p = 0.35, treatment 1 of 29 (3.4%), control 4 of 31 (12.9%), NNT 11.

risk of case, 85.3% lower, RR 0.15, p = 0.24, treatment 0 of 29 (0.0%), control 3 of 31 (9.7%), NNT 10, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Ahanchian et al., 31 May 2021, Double Blind Randomized Controlled Trial, placebo-controlled, Iran, peer-reviewed, 14 authors, study period July 2020 - August 2020, trial IRCT20101020004976N6.

This Paper Probiotics All

Synbiotic for Prevention of SARS-Cov2 Infection in High Risk Hospital Staffs: A Randomized Controlled Trial

Hamid Ahanchian, Alireza Ranjbar, Hamidreza Reihani, Arash Peivandi Yazdi, Seyed Ali Jafari, Mohammad Ali Kiani, Rana Tafrishi, Nasrinsadat Motevalli Haghi, Nasrin Moazzen, Ali Khalshour, Faezeh Mirzaei, Zahra Abbasi Shaye, Sadegh Ebrahimi, Hamidreza Kianifar

Open Journal of Nursing, doi:10.4236/ojn.2021.115025

Introduction: COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 increasingly involves people worldwide. Probiotics can improve immune system functions via different mechanisms. We proposed that Synbiotic Lactocare ® may also reduce SARS-Cov2 infection in high-risk medical staff working in COVID-19 hospital wards. Method: In a randomized, controlled trial, 60 hospital staff without any history of clinical or laboratory evidence of SARS-Cov2 infection were received either once-daily oral synbiotic capsule (Lactocare ® ) that contains 1 billion CFU/Cap of L. (Lactobacillus) casei, L.

Conflicts of Interest The authors declare no conflicts of interest regarding the publication of this paper.

References

Ahanchian, A Multi-Strain Synbiotic May Reduce Viral Respiratory Infections in Asthmatic Children: A Randomized Controlled Trial, Electronic Physician, doi:10.19082/2833

Ahanchian, Respiratory Viral Infections in Children with Asthma: Do They Matter and Can We Prevent Them, BMC Pediatrics, doi:10.1186/1471-2431-12-147

Ahanchian, Synbiotics in Children with Cow's Milk Allergy: A Randomized Controlled Trial, Iranian Journal of Pediatrics

Akour, Probiotics and COVID-19: Is There Any Link?, Letters in Applied Microbiology, doi:10.1111/lam.13334

Antunes, Microbiota-Derived Acetate Protects against Respiratory Syncytial Virus Infection through a GPR43-Type 1 Interferon Response, Nature Communications

Baud, Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic, Frontiers in Public Health, doi:10.3389/fpubh.2020.00186

Chan, Preventing Respiratory Tract Infections by Synbiotic Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Advances in Nutrition, doi:10.1093/advances/nmaa003

Dhar, Mohanty, Gut Microbiota and Covid-19-Possible Link and Implications, Virus Research, doi:10.1016/j.virusres.2020.198018

Emre, The Effect of Probiotics on Prevention of Upper Respiratory Tract Infections in the Paediatric Community-A Systematic Review, Beneficial Microbes, doi:10.3920/BM2019.0119

Farid, Effect of a New Synbiotic Mixture on Atopic Dermatitis in Children: A Randomized-Controlled Trial, Iranian Journal of Pediatrics

Fata, Weber, Mohajeri, Probiotics and the Gut Immune System: Indirect Regulation, Probiotics and Antimicrobial Proteins, doi:10.1007/s12602-017-9322-6

Fábrega, Intestinal Anti-Inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice, Frontiers in Microbiology, doi:10.3389/fmicb.2017.01274

Galdeano, Beneficial Effects of Probiotic Consumption on the Immune System, Annals of Nutrition and Metabolism, doi:10.1159/000496426

Geva-Zatorsky, Mining the Human Gut Microbiota for Immunomodulatory Organisms, Cell, doi:10.1016/j.cell.2017.01.022

Hao, Dong, Wu, Probiotics for Preventing Acute Upper Respiratory Tract Infections, Cochrane Database of Systematic Reviews, doi:10.1002/14651858.CD006895.pub3

Hoffmann, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, doi:10.1016/j.cell.2020.02.052

Jafari, Effects of Probiotics on Quality of Life in Children with Cystic Fibrosis; a Randomized Controlled Trial, Iranian Journal of Pediatrics

Kianifar, Probiotic for Irritable Bowel Syndrome in Pediatric Patients: A Randomized Controlled Clinical Trial, Electronic Physician

Kianifar, Synbiotic in the Management of Infantile Colic: A Randomised Controlled Trial, Journal of Paediatrics and Child Health, doi:10.1111/jpc.12640

Kotzampassi, Benefits of a Synbiotic Formula (Synbiotic 2000Forte®) in Critically Ill Trauma Patients: Early Results of a Randomized Controlled Trial, World Journal of Surgery, doi:10.1007/s00268-005-0653-1

Mak, Chan, Ng, Probiotics and COVID-19: One Size Does Not Fit All, The Lancet Gastroenterology and Hepatology, doi:10.1016/S2468-1253(20)30122-9

Meng, COVID-19 and Anosmia: A Review Based on Up-to-Date Knowledge, American Journal of Otolaryngology, doi:10.1016/j.amjoto.2020.102581

Moazzen, How to Boost Our Immune System against Coronavirus Infection?, Archives of Bone and Joint Surgery

Moreno De Leblanc, Oral Administration of L. casei CRL 431 Increases Immunity in Bronchus and Mammary Glands, European Journal of Inflammation, doi:10.1177/1721727X0500300105

Ramírez-Aldana, Gomez-Verjan, Bello-Chavolla, Spatial Analysis of COVID-19 Spread in Iran: Insights into Geographical and Structural Transmission Determinants at a Province Level, PLoS Neglected Tropical Diseases, doi:10.1371/journal.pntd.0008875

Sly, Primary Prevention of Severe Lower Respiratory Illnesses in At-Risk Infants Using the Immunomodulator OM-85, Journal of Allergy and Clinical Immunology, doi:10.1016/j.jaci.2019.05.032

Villena, Kitazawa, The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?, Frontiers in Physiology, doi:10.3389/fphys.2020.00699

Walton, Gibson, Hunter, Mechanisms Linking the Human Gut Microbiome to Prophylactic and Treatment Strategies for COVID-19, British Journal of Nutrition, doi:10.1017/S0007114520003980

Wang, Risk Factors of SARS-CoV-2 Infection in Healthcare Workers: A Retrospective Study of a Nosocomial Outbreak, Sleep Medicine: X, doi:10.1016/j.sleepx.2020.100028

Young, Groocock, Kariuki, Integrated Control of Ticks and Tick-Borne Diseases of Cattle in Africa, Parasitology, doi:10.1017/S0031182000058388

Zhang, Prospective Study of Probiotic Supplementation Results in Immune Stimulation and Improvement of Upper Respiratory Infection Rate, Synthetic and Systems Biotechnology, doi:10.1016/j.synbio.2018.03.001

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0